Clinical Challenges With Concentrated Insulins: Setting the Record Straight

Por Brusko, Cynthia S.A., Taylor, April D., Jackson, Jeffrey A., Bunck, Mathijs C.
Publicado no Diabetes Spectr (2017)

Autonomous prolactin secretion in two male-to-female transgender patients using conventional oestrogen dosages

Por Bunck, Mathijs C, Debono, Miguel, Giltay, Erik J, Verheijen, Andreas T, Diamant, Michaela, Gooren, Louis J
Publicado em 2009

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

Por Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Publicado em 2010

Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes

Por Bunck, Mathijs C., Cornér, Anja, Eliasson, Bjorn, Heine, Robert J., Shaginian, Rimma M., Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Diamant, Michaela
Publicado em 2011

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trial

Por Bunck, Mathijs C., Diamant, Michaela, Cornér, Anja, Eliasson, Bjorn, Malloy, Jaret L., Shaginian, Rimma M., Deng, Wei, Kendall, David M., Taskinen, Marja-Riitta, Smith, Ulf, Yki-Järvinen, Hannele, Heine, Robert J.
Publicado em 2009

Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity

Por van der Pouw Kraan, Tineke C. T. M., Chen, Weena J., Bunck, Mathijs C. M., van Raalte, Daniel H., van der Zijl, Nynke J., van Genugten, Renate E., van Bloemendaal, Liselotte, Baggen, Josefien M., Serné, Erik H., Diamant, Michaela, Horrevoets, Anton J. G.
Publicado no BMC Med Genomics (2015)